RhumbLine Advisers’s MEDIROM Healthcare Technologies MRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MRM
GSC
RhumbLine Advisers's MRM Position: Q3 2026 in Review
RhumbLine Advisers held its MEDIROM Healthcare Technologies (MRM) position steady in Q3 2026 at 3,104 shares worth $2.04K. The position accounts for ﹤0.01% of the portfolio, ranked #3927.
RhumbLine Advisers first reported a position in MRM in Q2 2025 and has held it in 6 quarters since. The position peaked at $8.25K in Q4 2025. 7 funds tracked by Wall St. Rank hold MRM as of Q3 2026.
- RhumbLine Advisers held 3,104 shares of MEDIROM Healthcare Technologies worth $2.04K as of Q3 2026.
- RhumbLine Advisers left its MEDIROM Healthcare Technologies share count unchanged in Q3 2026.
- MEDIROM Healthcare Technologies made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3927 holding.
- RhumbLine Advisers first reported a position in MEDIROM Healthcare Technologies in Q2 2025 and has held it in 6 quarters since.
- RhumbLine Advisers's MEDIROM Healthcare Technologies position peaked at $8.25K in Q4 2025.
- 7 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.